IKT

NASDAQStock

Inhibikase Therapeutics, Inc.

$2.00+0.01 (+0.50%)

52-Week Range

$1.41

$2.47

Key Stats

Market Cap

142.0M

P/E Ratio

4.17

Dividend Yield

—

Beta

0.80

Volume

1.0M

Avg Volume

4.7M

Performance

+21.34%

+22.84%

+24.37%

YTD

+2.05%

-11.56%

-52.62%

-94.92%

Price Chart

ETF Exposure

IKT is held by 33 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
IWC	iShares Micro-Cap ETF	0.03%	157,263	$318K	$1.27B	0.60%
IWN	iShares Russell 2000 Value ETF	0.01%	460,982	$931K	$12.21B	0.24%
VTWV	Vanguard Russell 2000 Value ETF	0.01%	38,439	$58K	$1.00B	0.06%
SC0K.DE	Invesco Russell 2000 UCITS ETF	0.00%	0	$0	$189.7M	0.45%
IWM	iShares Russell 2000 ETF	0.00%	1,254,589	$2.5M	$69.44B	0.19%
RSSL	Global X - Russell 2000 ETF	0.00%	28,395	$51K	$1.33B	0.08%
XRS2.DE	Xtrackers Russell 2000 UCITS ETF 1C	0.00%	48,631	$84K	$2.11B	0.30%
XRSU.L	Xtrackers Russell 2000 UCITS ETF 1C	0.00%	48,631	$97K	$2.43B	0.30%
XSU.TO	iShares U.S. Small Cap Index ETF (CAD-Hedged)	0.00%	1,254,589	$25K	$677.7M	0.36%
UWM	ProShares - Ultra Russell2000	0.00%	3,592	$7K	$264.2M	1.07%
VTWO	Vanguard Russell 2000 ETF	0.00%	288,601	$433K	$14.50B	0.06%
URTY	ProShares - UltraPro Russell2000	0.00%	3,616	$7K	$284.9M	1.08%
HDG	ProShares - Hedge Replication ETF	0.00%	67	$133	$23.2M	0.95%
IWO	iShares Russell 2000 Growth ETF	0.00%	62,002	$125K	$12.36B	0.24%
SMMD	iShares Russell 2500 ETF	0.00%	18,796	$38K	$2.28B	0.23%
VXF	Vanguard Extended Market ETF	0.00%	371,555	$557K	$84.10B	0.05%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	4	$8	$60.6M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	15	$29	$80.3M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	25	$50	$80.4M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	28	$57	$63.0M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	34	$68	$57.9M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	28	$56	$42.1M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	19	$37	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	14	$28	$21.0M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	6	$12	$9.3M	0.12%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	168	$342	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	6,017	$12K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	29	$59	$337.7M	0.32%
VTHR	Vanguard Russell 3000 ETF	0.00%	6,410	$10K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	3,425,978	$5.1M	$2.10T	0.03%
VTWG	Vanguard Russell 2000 Growth ETF	0.00%	3,660	$5K	$1.50B	0.06%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	18,020	$37K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	1,553	$3K	$1.29B	0.17%

About IKT ETF Exposure

Inhibikase Therapeutics, Inc. (IKT) is held by 33 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 142.0M, IKT is a widely held institutional stock. The stock currently trades at $2.00. Investors can gain exposure to IKT through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold IKT, sorted by portfolio weight.